Results 191 to 200 of about 8,546 (232)

EVOLUTION OF BASFI AND PAIN IN PATIENTS TREATED BY THE URUGUAYAN SPONDILOARTROPATHIES GROUP (GUES)

JCR: Journal of Clinical Rheumatology, 2006
Pizzol De, G G, V V, Margarita
openalex   +2 more sources

HOW TO DEAL WITH MISSING ITEMS IN BASDAI AND BASFI

, 2012
Sofía Ramiro, Astrid van Tubergen, D. van der Heijde, Robert Landewé   +3 more
openalex   +2 more sources

Spondyloarthritis in women: differences in disease onset, clinical presentation, and Bath Ankylosing Spondylitis Disease Activity and Functional indices (BASDAI and BASFI) between men and women with spondyloarthritides

Clinical Rheumatology, 2010
Euthalia Roussou, Shahzabeen Sultana
openalex   +2 more sources

PRM57 Developing BASDAI and BASFI Predictive Equations From Clinical Trial Data of Golimumab for Severe, Active Ankylosing Spondylitis in Adults [PDF]

Value in Health, 2012
M.A. Chaudhary, Benjamin Hsu, N. Muszbek, Irina Proskorovsky, J. Farrell   +4 more
openalex   +2 more sources

Some of the next articles are maybe not open access.

Related searches:

Efficacy and safety of infliximab in patients with ankylosing spondylitis: Results of a randomized, placebo‐controlled trial (ASSERT)

Arthritis and Rheumatism, 2005
Joachim Sieper, Juergen Braun, Désirée M Van Der Heijde   +2 more
exaly   +2 more sources

SAT0230 The Minimum Clinically Important Improvement and Patient Acceptable Symptom State in Basdai and Basfi in Patients with Ankylosing Spondylitis

Annals of the Rheumatic Diseases, 2013
Background The minimum clinically important improvement (MCII) and patient acceptable symptom state (PASS) are clinically relevant measures that report the patient condition. These can be established using cutoffs in BASDAI and BASFI to assess disease activity and functional disability respectively, in patients with Ankylosing Spondylitis (AS ...
Milla J. Kviatkovsky, Sofía Ramiro, R. Landewé, Florence Tubach, Maxime Dougados, Désirée van der Heijde   +5 more
openalex   +2 more sources

Persistance d'importantes variations du BASDAI et du BASFI après trois cures d'infliximab : difficultés à définir un échappement dans les spondylarthropathies (SpA)

Revue du Rhumatisme, 2006
L. Tortellijer, Florence Chevalet-Muller, Delphine Lavy-Bregeon, Yves Maugars, Jean‐Marie Berthelot   +4 more
openalex   +2 more sources

Estudio de concordancia y equivalencia entre los cuestionarios Barthel, Lawton, HAQ y BASFI en pacientes con artritis reumatoide y espondiloartritis

, 2018
Treball Final de Grau en Medicina. Codi: MD1158. Curs acadèmic: 2017/2018 Background: Due to the chronic and invalidating nature of rheumatic diseases, which affect the quality of life, it is vital to use instruments that help us evaluate the ...
María Copoví Moya
openalex   +1 more source

Evaluation of a Romanian version of the Bath Ankylosing Spondylitis Functional Index (BASFI) in patients with spondylarthropathies.

Romanian journal of internal medicine = Revue roumaine de medecine interne, 2004
To develop a Romanian version of the Bath Ankylosing Spondylitis Functional Index (BASFI) and to determine its metric properties in patients with spondylarthropathies (SpA).A Romanian version of BASFI was obtained after translation, back-translation and pretesting.
Gabriela Udrea, Camelia Ciobanu, Carina Mihai, Stoica, S Suţeanu, van der Heijde D, van der Linden S   +6 more
openalex   +2 more sources

Grande variabilité hebdomadaire des scores BASDAI et BASFI : intérêt de plusieurs évaluations avant d’initier ou d’arrêter un traitement par anti-TNFα dans les spondylarthropathies ?

Revue du Rhumatisme, 2008
Resume Objectif Etudier, a l’echelon individuel, la variabilite des scores BASDAI, BASFI et HAQ dans les spondylarthropathies (SpA). Methodes Recueil prospectif hebdomadaire, pendant 30 semaines, chez 24 SpA. Une etude retrospective des BASDAI, BASFI et HAQ apres la troisieme cure d’infliximab a egalement ete realisee chez 31 patients traites ...
Jean-Marie Berthelot, Lætitia Tortellier, Delphine Lavy-Bregeon, Benoît Le Goff, Yves Maugars   +4 more
openaire   +1 more source